Gujarat Attracts Global Healthcare Brands
Gujarat perhaps going to be the next hub of Indian healthcare enterprise. After Vicks and Colgate Palmolive, US-based Abbott Laboratories […]
Tags: biotechnology, Business/Finance, Clinical Research, Commissioner, Company Expansion, Food and Drugs Control Administration, Funding, Gujarat, Health/Medical/Pharmaceuticals, healthcare enterprise, India, Israel, Koshia, M&A, manufacturing, Mark Dolan, New Jersey, pharmaceutical, Pharmaceutical sciences, Pharmaceuticals in India, Pharmaceutics, Pharmacology, Rs, Sanand, Scotland, Tecnova India, Teva Pharmaceutical Industries, TEVA TA`ASIYOT FARMATSEVTIYOT BE`AM, United States
Glenmark Pharmaceuticals Recalls Skin Ointment
Glenmark Pharmaceuticals has initiated voluntary recall of a skin ointment from the US after the drug exceeded the permissible impurity level.
Business news
Pfizer considers outsourcing manufacturing to India, ChinaUS-based pharmaceutical giant, Pfizer, is looking to cut costs by outsourcing as much as […]
US hospital unveils plans for US$130m cancer facility
The John Theurer Cancer Center at Hackensack University Medical Center in New Jersey, US, has unveiled a US$130m cancer facility.
OR Technology upgraded by NJ health system
The largest integrated delivery network in southern New Jersey, Virtua, is rolling out new information technology for operating rooms in nine facilities.
Perot Systems Buys Tellurian To Expand Health-Care Services Reach
Perot Systems will significantly bolster its health-care interests after acquiring Tellurian Networks, a managed services provider of electronic medical records (EMR) and practice management (PM) applications.
IBM delivers new mobility services for healthcare industry
IBM has announced new services to help healthcare organisations implement wireless mobility solutions to meet their 21st century objectives towards efficiency and quality.
Venture capitalists’ interest in Biotech raises record USD 9.1 bn
Venture capitalists pumped a record USD 9.1 billion into privately-held US biotechnology and medical device companies last year, in hopes of making discoveries they can sell to larger drugmakers.
NEWS REVIEW – BUSINESS
[This article was published in the January 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News
Pfizer is considering outsourcing its manufacturing to India and China
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia, particularly in India and China.
Pfizer is considering outsourcing its manufacturing to India and China
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia, particularly in India and China.
NPIL, Merck in research deal for cancer drugs
Nicholas Piramal (NPIL) has reportedly signed a research deal potentially worth a maximum revenue of USD 350 million with US pharmaceutical giant Merck & Co to carry out early discovery and development of two new cancer drugs, the two companies said on Monday.
